Further Background

Mark has had major involvement with commissioning structures and HTA bodies including previous experience working with:

• National Specialised Commissioning Advisory Group
• National Specialised Commissioning Group
• Advisory Group for National Specialised Services
• NICE Highly Specialised Technology programme
• NHS England Specialised Services Group
• NHS England Clinical Priorities Advisory Group
• Public Health England
• Rare Diseases Advisory Group

Additional involvement spans the remainder of key HTA and commissioning groups across the UK and Ireland including:

• Scottish Medicines Consortium
• National Services Division Scotland
• All Wales Medicines Strategy Group
• National Centre for Pharmacoeconimics (Ireland)
• Irish Health Service Executive

Please contact us for further information.